Brain Metastases From Melanoma: Therapy at the Crossroads

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 96; no. 4; pp. 713 - 716
Main Authors Kirkpatrick, John P., MD, PhD, Laack, Nadia N., MD, Soltys, Scott G., MD, Halasz, Lia M., MD, Breneman, John C., MD, Shih, Helen A., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
Author Kirkpatrick, John P., MD, PhD
Soltys, Scott G., MD
Laack, Nadia N., MD
Shih, Helen A., MD
Breneman, John C., MD
Halasz, Lia M., MD
Author_xml – sequence: 1
  fullname: Kirkpatrick, John P., MD, PhD
– sequence: 2
  fullname: Laack, Nadia N., MD
– sequence: 3
  fullname: Soltys, Scott G., MD
– sequence: 4
  fullname: Halasz, Lia M., MD
– sequence: 5
  fullname: Breneman, John C., MD
– sequence: 6
  fullname: Shih, Helen A., MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27788943$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1P3DAQtRAVLB__AKEce8kyYydrh0OlsiqlElUPgMTNcpyJcEjirZ1F2n-PlwUOvVR60mg0b97MvDli-6MfibEzhDkCLi66ueuCr1dznrI5JEC5x2aoZJWLsnzcZzMQC8hFKh-yoxg7AECUxQE75FIqVRVixqqrYNyY_abJxASK2XXwQ8p7M_rBXGb3TxTMapOZKZueKFsGH2Pwpokn7Etr-kin7_GYPVz_uF_e5Ld_fv5afr_NbYFyylFKkLUCMgKkoJaL2rRKIhpeLpTlBmsuZFspoaAiVVaqFUXDEeuytI2V4ph93emugv-7pjjpwUVLfVqQ_DpqVCIJKVUUiVrsqPZtS2r1KrjBhI1G0FvTdKd3pumtaRoSoExt5-8T1vVAzWfTh0uJ8G1HoHTni6Ogo3U0WmpcIDvpxrv_TfhXwPZudNb0z7Sh2Pl1GJOHGnXkGvTd9nHbv-FCpMgr8QqecZQR
CitedBy_id crossref_primary_10_1016_j_ijrobp_2019_02_030
crossref_primary_10_1212_CON_0000000000000551
crossref_primary_10_1016_j_ijrobp_2017_02_223
crossref_primary_10_1016_j_ijrobp_2019_08_026
Cites_doi 10.1016/S0140-6736(12)60868-X
10.3171/2014.9.JNS141425
10.1016/j.ijrobp.2016.01.038
10.1016/j.ijrobp.2015.03.003
10.1056/NEJMct0806951
10.1186/s40425-015-0095-8
10.1016/S1470-2045(15)00141-2
10.1093/annonc/mdv622
10.1056/NEJMoa1504030
10.1002/cam4.315
10.1056/NEJMoa1103782
10.1007/s11060-016-2072-6
10.1056/NEJMoa1003466
10.1016/S1470-2045(12)70090-6
10.3171/2012.5.JNS111929
10.1038/nature00766
10.1016/j.ijrobp.2015.01.004
10.1001/jamaoncol.2015.2756
10.1016/S1470-2045(12)70431-X
10.1200/JCO.2015.60.9503
10.1097/CMR.0b013e32835f3d90
10.1016/j.ejca.2013.11.002
10.1200/JCO.2011.38.0527
10.1093/neuonc/nov093
ContentType Journal Article
Copyright Elsevier Inc.
2016 Elsevier Inc.
Copyright_xml – notice: Elsevier Inc.
– notice: 2016 Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ijrobp.2016.06.005
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
Editor Soltys, Scott G.
Shih, Helen A.
Breneman, John C.
Halasz, Lia M.
Laack, Nadia N.
Kirkpatrick, John P.
Editor_xml – sequence: 1
  givenname: John P.
  surname: Kirkpatrick
  fullname: Kirkpatrick, John P.
– sequence: 2
  givenname: Nadia N.
  surname: Laack
  fullname: Laack, Nadia N.
– sequence: 3
  givenname: Scott G.
  surname: Soltys
  fullname: Soltys, Scott G.
– sequence: 4
  givenname: Lia M.
  surname: Halasz
  fullname: Halasz, Lia M.
– sequence: 5
  givenname: John C.
  surname: Breneman
  fullname: Breneman, John C.
– sequence: 6
  givenname: Helen A.
  surname: Shih
  fullname: Shih, Helen A.
EndPage 716
ExternalDocumentID 10_1016_j_ijrobp_2016_06_005
27788943
S0360301616303029
1_s2_0_S0360301616303029
Genre Comment
Journal Article
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
1B1
1P~
1RT
1~5
29J
4.4
457
4G.
53G
5RE
5VS
7-5
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAWTL
AAXUO
ABEFU
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ADBBV
ADMUD
ADPAM
ADVLN
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFRHN
AFTJW
AGRDE
AHHHB
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
DU5
EBS
EFJIC
EJD
F5P
FDB
FEDTE
FGOYB
FIRID
G-2
GBLVA
HED
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LX3
M41
MO0
NQ-
O9-
OC~
OO-
R2-
RIG
RNS
ROL
RPZ
SAE
SDG
SEL
SES
SEW
SSZ
UDS
UV1
X7M
XH2
XPP
Z5R
ZGI
~S-
AAIAV
AGZHU
ALXNB
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c417t-17707b80ea3073ef23baf8711a2568c2a1b237f983809e8598f34d211b55cdc73
ISSN 0360-3016
IngestDate Sat Aug 17 00:42:48 EDT 2024
Thu Sep 26 17:03:32 EDT 2024
Wed Oct 16 00:59:50 EDT 2024
Fri Feb 23 02:28:08 EST 2024
Tue Oct 15 22:52:47 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c417t-17707b80ea3073ef23baf8711a2568c2a1b237f983809e8598f34d211b55cdc73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
PMID 27788943
PQID 1835688844
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1835688844
crossref_primary_10_1016_j_ijrobp_2016_06_005
pubmed_primary_27788943
elsevier_sciencedirect_doi_10_1016_j_ijrobp_2016_06_005
elsevier_clinicalkeyesjournals_1_s2_0_S0360301616303029
PublicationCentury 2000
PublicationDate 2016-11-15
PublicationDateYYYYMMDD 2016-11-15
PublicationDate_xml – month: 11
  year: 2016
  text: 2016-11-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of radiation oncology, biology, physics
PublicationTitleAlternate Int J Radiat Oncol Biol Phys
PublicationYear 2016
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Hauschild, Grob, Demidov (bib17) 2012; 380
Knisely, Yu, Flanigan (bib7) 2012; 117
Mathew, Tam, Ott (bib8) 2013; 23
Ahmed, Stallworth, Kim (bib12) 2016; 27
Lin, DeAngelis (bib23) 2015; 33
Hodi, O'Day, McDermott (bib5) 2010; 363
Demaria, Golden, Formenti (bib22) 2015; 1
Schoenfeld, Mahadevan, Floyd (bib10) 2015; 3
Long, Trefzer, Davies (bib19) 2012; 13
Dummer, Goldinger, Turtschi (bib18) 2014; 50
Ly, Bagshaw, Anker (bib20) 2015; 123
Soltys, Kirkpatrick, Laack (bib24) 2015; 92
Margolin, Ernstoff, Hamid (bib6) 2012; 13
Tazi, Hathaway, Chiuzan (bib11) 2015; 4
Sperduto, Kased, Roberge (bib3) 2012; 30
Ajithkumar, Parkinson, Fife (bib2) 2015; 16
Chapman, Hauschild, Robert (bib16) 2011; 364
Anker, Grossmann, Atkins (bib21) 2016; 95
Larkin, Hodi, Wolchok (bib13) 2015; 373
Suh (bib1) 2010; 362
Patel, Lawson, Kudchadkar (bib9) 2015; 17
Davies, Bignell, Cox (bib15) 2002; 417
Kiess, Wolchok, Barker (bib4) 2015; 92
Wolf, Zia, Verma (bib14) 2016; 127
25754629 - Int J Radiat Oncol Biol Phys. 2015 Jun 1;92 (2):368-75
26270858 - JAMA Oncol. 2015 Dec;1(9):1325-32
26712903 - Ann Oncol. 2016 Mar;27(3):434-41
26852222 - J Neurooncol. 2016 May;127(3):607-15
Mathew (10.1016/j.ijrobp.2016.06.005_bib8) 2013; 23
Ly (10.1016/j.ijrobp.2016.06.005_bib20) 2015; 123
Schoenfeld (10.1016/j.ijrobp.2016.06.005_bib10) 2015; 3
Demaria (10.1016/j.ijrobp.2016.06.005_bib22) 2015; 1
Ajithkumar (10.1016/j.ijrobp.2016.06.005_bib2) 2015; 16
Margolin (10.1016/j.ijrobp.2016.06.005_bib6) 2012; 13
Hauschild (10.1016/j.ijrobp.2016.06.005_bib17) 2012; 380
Sperduto (10.1016/j.ijrobp.2016.06.005_bib3) 2012; 30
Hodi (10.1016/j.ijrobp.2016.06.005_bib5) 2010; 363
Wolf (10.1016/j.ijrobp.2016.06.005_bib14) 2016; 127
Kiess (10.1016/j.ijrobp.2016.06.005_bib4) 2015; 92
Davies (10.1016/j.ijrobp.2016.06.005_bib15) 2002; 417
Suh (10.1016/j.ijrobp.2016.06.005_bib1) 2010; 362
Patel (10.1016/j.ijrobp.2016.06.005_bib9) 2015; 17
Long (10.1016/j.ijrobp.2016.06.005_bib19) 2012; 13
Tazi (10.1016/j.ijrobp.2016.06.005_bib11) 2015; 4
Lin (10.1016/j.ijrobp.2016.06.005_bib23) 2015; 33
Chapman (10.1016/j.ijrobp.2016.06.005_bib16) 2011; 364
Larkin (10.1016/j.ijrobp.2016.06.005_bib13) 2015; 373
Ahmed (10.1016/j.ijrobp.2016.06.005_bib12) 2016; 27
Soltys (10.1016/j.ijrobp.2016.06.005_bib24) 2015; 92
Anker (10.1016/j.ijrobp.2016.06.005_bib21) 2016; 95
Knisely (10.1016/j.ijrobp.2016.06.005_bib7) 2012; 117
Dummer (10.1016/j.ijrobp.2016.06.005_bib18) 2014; 50
References_xml – volume: 1
  start-page: 1325
  year: 2015
  end-page: 1332
  ident: bib22
  article-title: Role of local radiation therapy in cancer immunotherapy
  publication-title: JAMA Oncol
  contributor:
    fullname: Formenti
– volume: 50
  start-page: 611
  year: 2014
  end-page: 621
  ident: bib18
  article-title: Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
  publication-title: Eur J Cancer
  contributor:
    fullname: Turtschi
– volume: 380
  start-page: 358
  year: 2012
  end-page: 365
  ident: bib17
  article-title: Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial
  publication-title: Lancet
  contributor:
    fullname: Demidov
– volume: 362
  start-page: 1119
  year: 2010
  end-page: 1127
  ident: bib1
  article-title: Stereotactic radiosurgery for the management of brain metastases
  publication-title: N Engl J Med
  contributor:
    fullname: Suh
– volume: 16
  start-page: e486
  year: 2015
  end-page: e497
  ident: bib2
  article-title: Evolving treatment options for melanoma brain metastases
  publication-title: Lancet Oncol
  contributor:
    fullname: Fife
– volume: 13
  start-page: 1087
  year: 2012
  end-page: 1095
  ident: bib19
  article-title: Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): A multicentre, open-label, phase 2 trial
  publication-title: Lancet Oncol
  contributor:
    fullname: Davies
– volume: 123
  start-page: 395
  year: 2015
  end-page: 401
  ident: bib20
  article-title: Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment
  publication-title: J Neurosurg
  contributor:
    fullname: Anker
– volume: 33
  start-page: 3475
  year: 2015
  end-page: 3484
  ident: bib23
  article-title: Treatment of brain metastases
  publication-title: J Clin Oncol
  contributor:
    fullname: DeAngelis
– volume: 92
  start-page: 368
  year: 2015
  end-page: 375
  ident: bib4
  article-title: Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: Safety profile and efficacy of combined treatment
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Barker
– volume: 23
  start-page: 191
  year: 2013
  end-page: 195
  ident: bib8
  article-title: Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
  publication-title: Melanoma Res
  contributor:
    fullname: Ott
– volume: 3
  start-page: 50
  year: 2015
  ident: bib10
  article-title: Ipilmumab and cranial radiation in metastatic melanoma patients: A case series and review
  publication-title: J Immunother Cancer
  contributor:
    fullname: Floyd
– volume: 117
  start-page: 227
  year: 2012
  end-page: 233
  ident: bib7
  article-title: Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
  publication-title: J Neurosurg
  contributor:
    fullname: Flanigan
– volume: 30
  start-page: 419
  year: 2012
  end-page: 425
  ident: bib3
  article-title: Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
  publication-title: J Clin Oncol
  contributor:
    fullname: Roberge
– volume: 27
  start-page: 434
  year: 2016
  end-page: 441
  ident: bib12
  article-title: Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
  publication-title: Ann Oncol
  contributor:
    fullname: Kim
– volume: 95
  start-page: 632
  year: 2016
  end-page: 646
  ident: bib21
  article-title: Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: Consensus guidelines from the Eastern Cooperative Oncology Group (ECOG)
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Atkins
– volume: 363
  start-page: 711
  year: 2010
  end-page: 723
  ident: bib5
  article-title: Improved survival with ipilimumab in patients with metastatic melanoma
  publication-title: N Engl J Med
  contributor:
    fullname: McDermott
– volume: 4
  start-page: 1
  year: 2015
  end-page: 6
  ident: bib11
  article-title: Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
  publication-title: Cancer Med
  contributor:
    fullname: Chiuzan
– volume: 364
  start-page: 2507
  year: 2011
  end-page: 2516
  ident: bib16
  article-title: Improved survival with vemurafenib in melanoma with BRAF V600E mutation
  publication-title: N Engl J Med
  contributor:
    fullname: Robert
– volume: 17
  start-page: 1312
  year: 2015
  end-page: 1321
  ident: bib9
  article-title: Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases
  publication-title: Neuro Oncol
  contributor:
    fullname: Kudchadkar
– volume: 417
  start-page: 949
  year: 2002
  end-page: 954
  ident: bib15
  article-title: Mutations of the BRAF gene in human cancer
  publication-title: Nature
  contributor:
    fullname: Cox
– volume: 13
  start-page: 459
  year: 2012
  end-page: 465
  ident: bib6
  article-title: Ipilimumab in patients with melanoma and brain metastases: An open-label, phase 2 trial
  publication-title: Lancet Oncol
  contributor:
    fullname: Hamid
– volume: 373
  start-page: 1270
  year: 2015
  end-page: 1271
  ident: bib13
  article-title: Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
  publication-title: N Engl J Med
  contributor:
    fullname: Wolchok
– volume: 127
  start-page: 607
  year: 2016
  end-page: 615
  ident: bib14
  article-title: Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases
  publication-title: J Neurooncol
  contributor:
    fullname: Verma
– volume: 92
  start-page: 963
  year: 2015
  end-page: 966
  ident: bib24
  article-title: Is less, more? The evolving role of radiation therapy for brain metastases
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Laack
– volume: 380
  start-page: 358
  year: 2012
  ident: 10.1016/j.ijrobp.2016.06.005_bib17
  article-title: Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)60868-X
  contributor:
    fullname: Hauschild
– volume: 123
  start-page: 395
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib20
  article-title: Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment
  publication-title: J Neurosurg
  doi: 10.3171/2014.9.JNS141425
  contributor:
    fullname: Ly
– volume: 95
  start-page: 632
  year: 2016
  ident: 10.1016/j.ijrobp.2016.06.005_bib21
  article-title: Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: Consensus guidelines from the Eastern Cooperative Oncology Group (ECOG)
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2016.01.038
  contributor:
    fullname: Anker
– volume: 92
  start-page: 963
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib24
  article-title: Is less, more? The evolving role of radiation therapy for brain metastases
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2015.03.003
  contributor:
    fullname: Soltys
– volume: 362
  start-page: 1119
  year: 2010
  ident: 10.1016/j.ijrobp.2016.06.005_bib1
  article-title: Stereotactic radiosurgery for the management of brain metastases
  publication-title: N Engl J Med
  doi: 10.1056/NEJMct0806951
  contributor:
    fullname: Suh
– volume: 3
  start-page: 50
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib10
  article-title: Ipilmumab and cranial radiation in metastatic melanoma patients: A case series and review
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-015-0095-8
  contributor:
    fullname: Schoenfeld
– volume: 16
  start-page: e486
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib2
  article-title: Evolving treatment options for melanoma brain metastases
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)00141-2
  contributor:
    fullname: Ajithkumar
– volume: 27
  start-page: 434
  year: 2016
  ident: 10.1016/j.ijrobp.2016.06.005_bib12
  article-title: Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdv622
  contributor:
    fullname: Ahmed
– volume: 373
  start-page: 1270
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib13
  article-title: Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1504030
  contributor:
    fullname: Larkin
– volume: 4
  start-page: 1
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib11
  article-title: Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
  publication-title: Cancer Med
  doi: 10.1002/cam4.315
  contributor:
    fullname: Tazi
– volume: 364
  start-page: 2507
  year: 2011
  ident: 10.1016/j.ijrobp.2016.06.005_bib16
  article-title: Improved survival with vemurafenib in melanoma with BRAF V600E mutation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1103782
  contributor:
    fullname: Chapman
– volume: 127
  start-page: 607
  year: 2016
  ident: 10.1016/j.ijrobp.2016.06.005_bib14
  article-title: Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases
  publication-title: J Neurooncol
  doi: 10.1007/s11060-016-2072-6
  contributor:
    fullname: Wolf
– volume: 363
  start-page: 711
  year: 2010
  ident: 10.1016/j.ijrobp.2016.06.005_bib5
  article-title: Improved survival with ipilimumab in patients with metastatic melanoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1003466
  contributor:
    fullname: Hodi
– volume: 13
  start-page: 459
  year: 2012
  ident: 10.1016/j.ijrobp.2016.06.005_bib6
  article-title: Ipilimumab in patients with melanoma and brain metastases: An open-label, phase 2 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70090-6
  contributor:
    fullname: Margolin
– volume: 117
  start-page: 227
  year: 2012
  ident: 10.1016/j.ijrobp.2016.06.005_bib7
  article-title: Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
  publication-title: J Neurosurg
  doi: 10.3171/2012.5.JNS111929
  contributor:
    fullname: Knisely
– volume: 417
  start-page: 949
  year: 2002
  ident: 10.1016/j.ijrobp.2016.06.005_bib15
  article-title: Mutations of the BRAF gene in human cancer
  publication-title: Nature
  doi: 10.1038/nature00766
  contributor:
    fullname: Davies
– volume: 92
  start-page: 368
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib4
  article-title: Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: Safety profile and efficacy of combined treatment
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2015.01.004
  contributor:
    fullname: Kiess
– volume: 1
  start-page: 1325
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib22
  article-title: Role of local radiation therapy in cancer immunotherapy
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2015.2756
  contributor:
    fullname: Demaria
– volume: 13
  start-page: 1087
  year: 2012
  ident: 10.1016/j.ijrobp.2016.06.005_bib19
  article-title: Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): A multicentre, open-label, phase 2 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70431-X
  contributor:
    fullname: Long
– volume: 33
  start-page: 3475
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib23
  article-title: Treatment of brain metastases
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.60.9503
  contributor:
    fullname: Lin
– volume: 23
  start-page: 191
  year: 2013
  ident: 10.1016/j.ijrobp.2016.06.005_bib8
  article-title: Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
  publication-title: Melanoma Res
  doi: 10.1097/CMR.0b013e32835f3d90
  contributor:
    fullname: Mathew
– volume: 50
  start-page: 611
  year: 2014
  ident: 10.1016/j.ijrobp.2016.06.005_bib18
  article-title: Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2013.11.002
  contributor:
    fullname: Dummer
– volume: 30
  start-page: 419
  year: 2012
  ident: 10.1016/j.ijrobp.2016.06.005_bib3
  article-title: Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.38.0527
  contributor:
    fullname: Sperduto
– volume: 17
  start-page: 1312
  year: 2015
  ident: 10.1016/j.ijrobp.2016.06.005_bib9
  article-title: Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/nov093
  contributor:
    fullname: Patel
SSID ssj0001174
Score 2.2665508
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 713
SubjectTerms Brain
Brain Neoplasms - secondary
Hematology, Oncology and Palliative Medicine
Humans
Melanoma
Radiology
Skin Neoplasms
Title Brain Metastases From Melanoma: Therapy at the Crossroads
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0360301616303029
https://dx.doi.org/10.1016/j.ijrobp.2016.06.005
https://www.ncbi.nlm.nih.gov/pubmed/27788943
https://search.proquest.com/docview/1835688844
Volume 96
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHfKTUHiLUoV52aHt1EGFaUVYpvYm2UnjrRuS6Ymfdnf449xHNtJRqmAvaRtLrXjc-zz-fh8xwi9y4uC5FHCvSjihTpknghy3wviDDQIeldRtNEWy2R2En05jU9Ho5-DqKVNIybZ9R95JbeRKpwDuSqW7H9ItvtTOAHfQb5wBAnD8Z9k_EHt7-AuZMMB49WyBhhaXcLvC15Wl9wEVKikAYay6E5bm1hxze61oPSmV3CQS2KtEhdoSFlmHa1F9AwX7Rfp14PO1udXbc7_cxvm635rh5_FR-296eKLv3Kub1qqMtyluatz-FQXjVaxozZ5xOffrs8U_fNaOxW4uxheNS4MnCgunyZxdtQtMAa-Jl3aYVlvdGvULxqMsUSTV425JvqpLUugnRKrydlqXQmVmBQnbaJWP-4tn13tP5zOsVcHE987UlVRNQGYCp_GGXMzITdmdcB8tnXrHbQfwGgHw-z-wfz7j3kHCLBJBm7f0jI42zDD7frtQki7ZkAtEjp-gO6bKYxzoPXxIRrJ8hG6uzBBGo9R2qql06ulo9TSsWr53jFK6fDGAaV0eqV8gk4-HR5PZ57ZocPLIkwaDxPiE0F9yZWpkEUQCl7AFBxzQNI0CzgWQUiKlIbUTyWNU1qEUR5gLOI4yzMSPkV7ZVXK58gRfi5zTADR-1SlPIKZX5KGWJAE0yziyRh5tlXYlU7EwmyE4orpVmSqFVkbqBmPEbFNxyzJGMyirE0vqtkuOQ6fNDBUw0sGuvWXMt9aGTEYpdXSGy9ltYGyYKKTUEqjaIyeaeF1bxEQQtUuCC9uXeOX6F7frV6hvWa9ka8BKzfijdHFX0ONtRU
link.rule.ids 315,783,787,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Brain+Metastases+From+Melanoma%3A+Therapy+at+the+Crossroads&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Kirkpatrick%2C+John+P.%2C+MD%2C+PhD&rft.au=Laack%2C+Nadia+N.%2C+MD&rft.au=Soltys%2C+Scott+G.%2C+MD&rft.au=Halasz%2C+Lia+M.%2C+MD&rft.date=2016-11-15&rft.issn=0360-3016&rft.volume=96&rft.issue=4&rft.spage=713&rft.epage=716&rft_id=info:doi/10.1016%2Fj.ijrobp.2016.06.005&rft.externalDBID=ECK1-s2.0-S0360301616303029&rft.externalDocID=1_s2_0_S0360301616303029
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03603016%2FS0360301616X00132%2Fcov150h.gif